SUMMARY The effects of intravenous procainamide infusion of 10-14 mg/kg body weight (i.e., 750 mg) of procainamide (PA) on reentry within the His-Purkinje system (HPS) were studied in 13 patients using His bundle electrograms and ventricular extrastimulus method. PA abolished reentry in eight patients (group 1) and decreased the width of reentry zone in the remaining five (group 2). At comparable S,S2 intervals, the S2H, intervals after PA were longer than control in all patients. In group 1 patients, after PA, reentry did not occur even at S2WH intervals that were significantly longer than control critical S2H2 intervals. In two of eight patients in group 1, PA abolished reentry by converting unidirectional block into bidirectional block in the antegrade limb (right bundle) of the reentry circuit. In the remaining six patients reentry was abolished because of consistent retrograde block of 82 impulse at some point between the site of stimulation and the His bundle recording site. In group 2, reentry was initiated after PA at approximately the same S,S% intervals as in control, but required significantly longer S2H2 intervals; in these patients the zone of reentry was shortened due to increase in effective refractory period of the ventricular muscle. PA significantly increased the functional refractory period of HPS and the effective refractory period of ventricular muscle. The results of this study differ from the previously reported effects of lower concentrations of PA which facilitated reentry within the same circuit. We conclude that the effects of PA on reentry are dose-related and can both facilitate and suppress reentry, depending on critical changes in conduction and refractoriness of the HPS.
REENTRY WITHIN the His-Purkinje system (HPS) where the path of reentry incorporates right and left bundle branches and the bundle of His has been demonstrated in man.' In this form of reentry, a critically timed ventricular premature beat (V,) induced during a constant paced ventricular cycle is followed by a spontaneous ventricular beat (V3). Its occurrence depends on both critical coupling (S,S2) intervals and a critical degree of retrograde conduction delays within the HPS. Unlike the experimental models of reentry2-8 involving isolated canine His bundle and Purkinje fibers, this clinical model is unique in that it permits the study of reentry within the HPS in intact heart. The ventricular extrastimulus method, using this reentry model, also facilitates the evaluation of drug effects simultaneously on conduction of HPS and refractoriness of both HPS and ventricular muscle, and thereby allows determination of the role of each of these parameters in the occurrence of reentry. Recently, we reported that the intravenous infusion of 500 mg of procainamide (PA) (5-8 mg/kg body weight) increased the width of zone of reentry, changed non-sustained into sustained reentry and permitted induction of reentry which could not be elicited before the administration of the drug. 9 We attributed these arrhythmia-facilitating effects to a critical change in the relationship between conduction and refractoriness within the HPS induced by PA.
We postulated that higher doses of PA might prevent reentry within the same reentrant circuit by caus-ing more pronounced changes in conduction and refractoriness of the HPS and by causing an increase in ventricular muscle refractoriness.
Methods
Right heart catheterization was performed in the postabsorptive, non-sedated state in 13 patients after obtaining an informed consent. The mean age of patients was 56.3 years (range 27-71 years). The electrophysiological studies were done for the following reasons: paroxysmal atrial tachycardia (three patients); sick sinus syndrome (five patients); mitral valve prolapse with atrial arrhythmias (three patients); exercise-induced ventricular tachycardia (one patient); and syncope of undetermined etiology (one patient). All but two (patients 2 and 5) had normal intraventricular conduction on ECG. None of the patients were on cardiac drugs for at least 48 hours before the study and all had normal serum electrolytes. His bundle electrograms were recorded as previously reported, using a tri-or quadripolar electrode catheter.'0 Additional electrode catheters were placed in the high right atrium and right ventricle for local recordings and electrical stimulation. Atrial and ventricular stimulation was performed using a programmed digital stimulator that delivered rectangular impulses at 1.5 msec duration and twice diastolic threshold strength. Intracardiac electrograms along with the electrocardiographic leads, I, II, and V, were recorded on paper moving at a speed of 100 mm/sec.
Antegrade and retrograde refractory periods were determined at one or more basic cycle lengths (A, A, or V, V,) using the extrastimulus method." The characteristics of the delivered stimuli or the site of stimulation were not changed in any patient during the course of the study.
All 13 patients consistently demonstrated reentry within the HPS during ventricular refractory period studies. In 11 patients the electrophysiological studies were performed before and 5 and 20 minutes after the intravenous administration of 10-14 mg/kg body weight (i.e., 750 mg) of PA infused at a rate of 50 mg/min. In the remaining two patients, similar studies were performed during control and immediately after the infusion of 500 mg of PA and again within 5 minutes after infusion of an additional 250 mg of PA. This additional dose of 250 mg of PA was given within 10 minutes after the infusion of 500 mg dose. The protocol for 500 mg study in these two patients is similar to our previous study.9 Blood samples for plasma PA levels were drawn before each repeat study. Plasma PA assays were carried out spectrophotometrically.
Statistical analyses were performed using the t test for paired data. Group I = patients 1-8; group 2 = patients 9-13. *In these patients the effects of both 500 and 750 mg doses of procainamide were tested.
Definitions of
Abbreviations: HPS = His-Purkinje system; CL = cycle length; PA = procainamide; ERP FRP = functional refractory period; VM = ventricular muscle.
Critical S2H2 Delays
During the control studies, critical S2H2 intervals ranged from 170-240 msec (mean 203 ± 25 msec). PA had the following effects on retrograde HisPurkinje conduction: 1) the coupling interval (S1S2) at which the H2 deflection emerged from the ventricular electrogram (V2) was longer than control in all patients; 2) at comparable S1S2 intervals the S2H2 intervals were longer than control values; 3) S2H2 intervals comparable to control critical S2H2 delays were attained in both group 1 and 2 patients; 4) in group I patients reentry did not become manifest even at S2H2 delays that were significantly longer than control critical S2H2 intervals; 5) in group 2, significantly longer S2H2 delays than in control were needed to initiate reentry (214 ± 27 vs 286 ± 13.7 msec; P < 0.005) (figs. 3A and B) and 6) the critical S2H2 intervals in group 2 were longer than the longest S2H2 intervals in group I at all but three cycle lengths (in patients 10, 11 and 13) (table 1) .
Longest S2H2 Intervals
In group 1 the longest S2H2 intervals after PA were equal to or longer than the longest control values in patients 1, 2, 6 and 8. In the remaining, longest S2H2 intervals exceeded the control critical S2H2 delays but were shorter than the control longest S2H2 intervals. In group 1 the average durations of the longest S2H2 intervals for control (257 ± 18.6 msec) and PA = effective refractory period; (243 ± 34 msec) were not significantly different. However, after PA reentry did not occur. In group 2, the longest S2H2 intervals after PA were longer than control values in all patients. In these patients, the average durations of the longest S2H2 intervals for control and PA were 253.7 ± 26 msec (range 210-300) and 299.3 ± 38 (range 220-340) (P < 0.005), respectively.
H-V Interval and H2V3 Interval
The average H-V interval during sinus rhythm was significantly longer after PA (58 ± 9 msec) than before (47 ± 8 msec) (P < 0.001). The H2V3 interval of reentrant beats was longer than the H-V interval of sinus beats both before and after PA. An inverse relationship existed between the S2H2 interval and the H2V3 intervals, i.e., the longer the S2H2 interval, the shorter the H2V3 interval. In group 2 the average shortest H2V3 interval after PA was significantly longer than control.
Zone of S2H2 Block S2H2 block is a form of retrograde gap within the HPS'4 where the S2 impulse blocks between the site of stimulation and the His bundle and is not followed by a His bundle deflection. Reentry did not occur when S2H2 block was present within the reentry zone, but was reestablished at shorter S,S2 intervals when S2 impulse resumed conduction to the bundle of His (fig 4) . retrogradely to the atria. Note low to high relationship ofA2. V2 is followed by a reentrant beat (V2) which is preceded by an H2 V3 of 70 msec which is longer than the H-V interval ofsinus beat. Reentry (V3) continued to occur at closer S1S2 intervals and longer S2H2 delays (panel C) up to the onset of effective refractory period ofthe ventricular muscle, which was reached at an S1S2 interval of200 msec (not shown in thefigure). In this patient the zone ofreentry (i.e., the range ofS1S2 intervals, 270-210, over which reentry occurred) was 60 msec. The QRS axis of V3 is different from that of V2. This may be related to the asynchronous propagation of V2 impulse via the right bundle branch. figure IA . At figure 3A . An antiarrhythmic drug could abolish a reentrant arrhythmia by altering one or more of the following features of reentry:'17'9 1) restoring conduction in the region of the unidirectional block; 2) converting unidirectional block into bidirectional block; and/or 3) causing the time needed for recovery of excitability of the antegrade limb or ventricular muscle to exceed the conduction delay.
PA and Reentry
The most likely mechanisms by which PA abolished reentry in group 1 patients are illustrated in figure 6. As shown in panel B, increased refractoriness after PA may have created bidirectional block or prolonged the recovery of excitability without actual block in the right bundle branch, thus preventing antegrade conduction of V2 through the right bundle branch with consequent absence of V3. Possibly, partial retrograde penetration into the right bundle by V2 impulse (due to PA-induced proximal delay within the ventricular muscle or at the muscle-Purkinje junction) without abolishing unidirectional block may have contributed to the delayed recovery of excitability and creation of bidirectional block in the right bundle branch. This mechanism seems applicable to patients 1 and 2, in whom S2H2 intervals significantly longer than control, critical S2H2 delays were attained but were not followed by V3, Increased refractoriness after PA makes disappearance of unidirectional block in the right bundle branch an unlikely mechanism for abolition of reentry in these patients. The most likely mechanism responsible for abolition of reentry in patients 3-8 is illustrated in panel C. PA increased the ERP of the HPS and either widened or created the S2H2 block zones. In this instance, the V2 impulse consistently encountered retrograde block in both bundle branches (panel C) or at the muscle Purkinje junction and was not followed by H2 deflection or V3 response.
Ventricular Muscle Refractoriness and Reentry
The results of our study suggest that refractoriness of ventricular muscle was not a primary determinant of reentry because the increased refractoriness of ventricular muscle after PA did not abolish reentry in any patient. Even though we did not determine the ERP of ventricular muscle following V2, it is reasonable to assume that the ERP of ventricle after V2 was shorter than that following V, because of shorter V1V2 cycle length. The absence of reentry after PA at S2H2 intervals that exceeded the ERP of ventricle make ventricular muscle a highly unlikely site of antegrade block and refractoriness of ventricle an unlikely determinant of reentry. After PA, reentry failed to occur because the refractoriness of antegrade limb (right 
is 750 msec in all panels. Rej'erence sinus beats are shown for control and procainamide studies. During control study (panels A and B) reentry occurred between S152 intervals of 300-240 msec. The critical S2H2 interval (panel A) and longest S2H2 interval (panel B) measure 220 and 270 msec, respectively. H-V interval measures 75 msec. After the infusion of500 mg ofprocainamide (panels C and D), reentry is initiated at a longer S,S2 interval of 320 msec. The critical S2H2 delay of 240 msec is longer than the control value and V3 is followed by another reentrant beat, V4. Reentry for more than one beat occurred between S1S2 intervals of 320-300 msec. Reentry occurred at shorter S,S2 intervals and longer S2H2 delays (panel D). The longest S2H2 interval is 300 msec. Reentry is abolished (panels E and F) after an additional dose of 250 mg ofprocainamide (total 750 mg). Note the absence of reentry at an S2H2 interval of290 msec (panel E) which is longer than the control longest S2H2 interval and the critical S2H2 interval of 500 mg of PA study (compare panels B and C with panel E). A t a shorter S1S2 interval of280 msec the S2 impulse retrogradely blockedproximal to the site of His bundle recording and is not followed by H2 deflection or V3 response. Such retrograde block ofS2 impulse occurred at shorter S1S2 intervals to the onset of the effective refractory period of the ventricular muscle, which was reached at an S1S2 interval of250 msec. Abbreviations are the same as in figure 1. It is not surprising that in group 2 patients reentry could still be induced after PA, because conduction delays in these patients were longer than the longest S2H2 intervals of group 2 patients. Persistence of reentry is critically dependent on an appropriate balance between refractory periods (i.e., V1V2 and V2V3 intervals) and conduction times (i.e., S2H2 and H2V3 intervals) Another explanation for the dose-dependent effect of PA on reentry is that PA in lower doses causes slower conduction of V3 impulse in the distal left bundle branch, allowing recovery of the more proximal left bundle branch, in turn permitting the propagation of V3 to the bundle of His (H3) and reexcitation of ventricles (V4). PA in higher doses causes a greater degree of prolongation of refractoriness and depression of excitability of the left bundle branch, causing retrograde block of V3 impulse in the left bundle branch, preventing repetitive reentry. Similarly, the absence of repetitive reentry during control studies may be explained as follows: The absence of depressed conduction in the distal left bundle branch might cause the V3 impulse to arrive at the proximal left bundle branch before recovery of its excitability, preventing depolarization of the His bundle (H3) and repetitive reentry. However, these are only possible explanations; more complex mechanisms may be involved in the occurrence or absence of repetitive reentry.
The results shown in the two patients in this study in whom PA widened the zone of reentry and caused repetitive reentry in small doses and abolished it in larger doses establish the dose-dependent effect of PA on reentry, and exclude the possibility that the effects of the drug on reentry were simply related to the difference between the patient groups. Furthermore, the groups in both studies are clinically similar and in each group the results were uniform. 1021 VOL 58, No 6, DECEMBER 1978 The effects of PA on electrophysiologic parameters at 5 and 20 minutes were similar although the plasma levels were different, suggesting that there is a discrepancy between plasma levels and tissue content after acute intravenous administration of the drug. When administered intravenously, the effects of PA on electrophysiological parameters are demonstrable only when serum levels are rather high.20 It has been reported previously24 that the plasma levels of PA after intravenous administration are only of limited value in studying drug effects.
Clinical Implications
Evidence from studies in patients with chronic recurrent ventricular tachycardia indicates that bundle branch reentry is a very rare mechanism of ventricular tachycardia.2528 However, since the requisite conditions for microreentry29, 30 which is assumed to be the mechanism of many cases of ventricular tachycardia, are the same as for macroreentry, it is tempting to postulate that PA abolishes these arrhythmias by mechanisms similar to the ones observed in this study. Wellens et al.24 found that in patients with chronic recurrent ventricular tachycardia, PA either abolished or modified the tachycardia zone, increased the ERP of right ventricle and lengthened the interval between the tachycardia, initiating premature beat and the first QRS complex of tachycardia. The latter observation strongly suggested reentry as the underlying mechanism of ventricular tachycardia. However, the mechanisms by which PA abolished reentry were not defined, since site of conduction delay and block could not be localized or measured. The results of this study suggest possible mechanisms by which PA can abolish various types of reentry in the HPS.
